Further, CLL reduces NK cell tumor cytotoxicity, reduces the expression of activatory NK cell receptors, and increases inhibitory NK cell receptor expression [48,95]. The gene discussed is KLRD1; the disease is B-cell chronic lymphocytic leukemia.